SLU7 and cancer: However, genetic mutations in the splicing factor or cis-regulatory RNA element, as well as abnormal expression of the splicing factor, can induce aberrant alternative splicing, which can promote the expression of undesired protein isoforms instead of the appropriate protein isoforms, leading to the progression of human diseases, including cancer [12].